Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 2;19(1):199.
doi: 10.1186/s12906-019-2618-1.

Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates

Amirthasingam Manoraj  1 , Vasanthi Thevanesam  2 , B M R Bandara  3 , Asela Ekanayake  2 , Veranja Liyanapathirana  4
Affiliations

Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates

Amirthasingam Manoraj et al. BMC Complement Altern Med. .

Abstract

Background: Triphala is an indigenous medical product used for a variety of diseases. This study was conducted to determine the effect of Triphala on antibiotic properties of gentamicin and oxacillin against multi-drug resistant organisms.

Methods: The checkerboard method was used to determine the synergy of Triphala with gentamicin and oxacillin against multi-drug resistant (MDR) Gram negative bacilli and methicillin-resistant Staphylococcus aureus (MRSA) using 2,3,5-triphenyltetrazolium chloride (TTC) assay. Fractional inhibitory concentration (FIC) index was calculated.

Results: When tested alone, the minimum inhibitory concentration (MIC) values of gentamicin for Gram negative isolates ranged from 8 to > 64 μg/ml. The MIC values of gentamicin for the Gram negative isolates ranged from 1 to 32 μg/ml when tested with Triphala. The FIC index was < 1 indicating a synergistic interaction in 10 of the 11 isolates and it was 1 indicating an additive effect in one isolate. The MIC values of oxacillin for MRSA isolates ranged from 4 to > 16 μg/ml with all MICs being equal to or higher than the resistance cut-off level. The MIC level with the addition of Triphala ranged from 0.25 to 4 μg/ml. FIC index was < 1 for all tested isolates indicating a synergistic interaction.

Conclusions: Triphala has synergistic activity with gentamicin against the selected MDR Gram negative bacilli and with oxacillin against MRSA isolates warranting further studies on the possibility of clinical use.

Keywords: Gentamicin; MDR gram negatives; MRSA; Oxacillin; Synergy; Triphala.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Mohan RC. Pathinen Siddharkal Arulich Seitha Pathrthaguna Cinthamani: Thamari library; 2006.
    1. Ayurvedic Pharmacopoeia Committee. The Ayurvedic formulary of India, part II. New Delhi: The controller of publications civil lines, Delhi, on behalf of the Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy; 2002.
    1. Murugesa Mudaliar KS. Siddha Materia Medica (Part I) (Medicinal Plants Division), Directorate of Indian Medicine & Homeopathy, Chennai-106; 2013.
    1. Baliga MS, Meera S, Mathai B, Rai MP, Pawar V, Palatty PL. Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a review. Chin J Integr Med. 2012;18(12):946–954. doi: 10.1007/s11655-012-1299-x. - DOI - PubMed
    1. Kesharwani A, Polachira SK, Nair R, Agarwal A, Mishra NN, Gupta SK. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement Altern Med. 2017;17(1):110. doi: 10.1186/s12906-017-1620-8. - DOI - PMC - PubMed

MeSH terms